Redpoint Bio Corporation (RPBC)
-OTC Markets | Prev Close: | 0.00 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | 1.47 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 0.01 - 0.35 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 23,249 |
|---|
| Market Cap: | 111.88K |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | 0.00 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Cargill Makes A Big Investment In The Future Of Steviaat Seeking Alpha(Mon, Mar 11)
- REDPOINT BIO CORP FinancialsEDGAR Online Financials(Fri, Aug 24)
- REDPOINT BIO CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Mon, Aug 20)
- REDPOINT BIO CORP Files SEC form 8-K, Termination of a Material Definitive AgreementEDGAR Online(Mon, Aug 13)
- REDPOINT BIO CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal OfEDGAR Online(Mon, Jun 18)
- REDPOINT BIO CORP FinancialsEDGAR Online Financials(Sat, May 26)
- REDPOINT BIO CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Mon, May 21)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 0.21 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Redpoint Bio Corporation, a development stage biotechnology company, focuses on the development of healthier foods and new approaches for the treatment of diabetes and obesity by understanding the biology of taste and its relationship to metabolis...
View More 
0.06%